These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 37241143)
1. Fosfomycin for Antibiotic Prophylaxis in Men Undergoing a Transrectal Prostate Biopsy: A Systematic Review and Meta-Analysis. Gu HM; Gu JS; Chung HS; Jung SI; Kwon D; Kim MH; Jung JH; Han MA; Kang SJ; Hwang EC; Dahm P Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241143 [No Abstract] [Full Text] [Related]
2. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis. Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542 [TBL] [Abstract][Full Text] [Related]
3. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis. Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative. Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847 [TBL] [Abstract][Full Text] [Related]
5. Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis. Noreikaite J; Jones P; Fitzpatrick J; Amitharaj R; Pietropaolo A; Vasdev N; Chadwick D; Somani BK; Rai BP Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):153-160. PubMed ID: 29487398 [TBL] [Abstract][Full Text] [Related]
6. The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate. Ongün S; Aslan G; Avkan-Oguz V Urol Int; 2012; 89(4):439-44. PubMed ID: 23006631 [TBL] [Abstract][Full Text] [Related]
7. Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study. Van Besien J; Uvin P; Weyne E; Van Praet C; Merckx L; De Graeve N; Van Renterghem K; Cartuyvels R; Van den Abeele AM Int J Urol; 2019 Mar; 26(3):391-397. PubMed ID: 30588680 [TBL] [Abstract][Full Text] [Related]
8. Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study. Delory T; Goujon A; Masson-Lecomte A; Arias P; Laurancon-Fretar A; Bercot B; Mongiat-Artus P; Molina JM; Lafaurie M Int J Infect Dis; 2021 Jan; 102():269-274. PubMed ID: 33129963 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic prophylaxis for elective hysterectomy. Ayeleke RO; Mourad S; Marjoribanks J; Calis KA; Jordan V Cochrane Database Syst Rev; 2017 Jun; 6(6):CD004637. PubMed ID: 28625021 [TBL] [Abstract][Full Text] [Related]
11. Fosfomycin trometamol vs ciprofloxacin for antibiotic prophylaxis before transrectal ultrasonography-guided prostate biopsy: A meta-analysis of clinical studies. Freitas DMO; Moreira DM Arab J Urol; 2019; 17(2):114-119. PubMed ID: 31285922 [No Abstract] [Full Text] [Related]
12. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study. Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of fosfomycin-based antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: A Korean multicenter study. Lim DG; Jung SI; Hwang EC; Kim TH; Bae S; Huh JS; Lee SJ; Chung H; Choi H Investig Clin Urol; 2023 May; 64(3):289-295. PubMed ID: 37341009 [TBL] [Abstract][Full Text] [Related]
15. Comparison of different regimens of short-term antibiotic prophylaxis in transrectal prostate biopsy. Krsakova E; Cermak A; Fedorko M J Hosp Infect; 2024 Mar; 145():83-87. PubMed ID: 38219833 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study. Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ BMC Urol; 2023 Dec; 23(1):211. PubMed ID: 38114968 [TBL] [Abstract][Full Text] [Related]
17. Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study. Yu SH; Jung SI; Ryu JW; Kim MS; Chung HS; Hwang EC; Kwon DD Investig Clin Urol; 2022 Nov; 63(6):663-670. PubMed ID: 36347556 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy. Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640 [TBL] [Abstract][Full Text] [Related]
19. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia. Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Kim MH; Narayan VM; Dahm P Cochrane Database Syst Rev; 2022 Mar; 3(3):CD012867. PubMed ID: 35349161 [TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]